Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



5-Star Small Caps Set to Soar: AngioDynamics

Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, medical device company AngioDynamics (Nasdaq: ANGO  ) has earned a coveted five-star ranking.

With that in mind, let's take a closer look at AngioDynamics and see what CAPS investors are saying about the stock right now.

AngioDynamics facts

Headquarters (founded)

Latham, N.Y. (1988)

Market Cap

$354.3 million


Health care equipment

Trailing-12-Month Revenue

$250.8 million


CEO Joseph DeVivo (since 2011)
CFO D. Joseph Gersuk (since 2007)

Return on Equity (average, past 3 years)



$30.5 million / $149.2 million


Boston Scientific (NYSE: BSX  )
C.R. Bard (NYSE: BCR  )

Sources: S&P Capital IQ and Motley Fool CAPS.

On CAPS, 86% of the 110 members who have rated AngioDynamics believe the stock will outperform the S&P 500 going forward.

Earlier this week, one of those Fools, ScalaAnalyst, succinctly summed up the AngioDynamics bull case for our community:

This is a nice small company that seems to do well competing against larger companies. Their growth rates the last few years along with their quarters show that company is going to stay with us for a while. ... Also the price to book ratio is also quite low. Altogether a good stock for the next year or three.

If you want market-thumping returns, you need to put together the best portfolio you can. Of course, despite a perfect five-star rating, AngioDynamics may not be your top choice.

We've found another growth play we are incredibly excited about -- excited enough to dub it "The Only Stock You Need to Profit from the NEW Technology Revolution." We have compiled a special free report for investors to uncover this stock today. The report is 100% free, but it won't be here forever, so click here to access it now.

Want to see how well (or not so well) the stocks in this series are performing? Follow the TrackPoisedTo CAPS account.

Read/Post Comments (1) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On November 29, 2012, at 10:36 AM, rsinj wrote:

    Debt is quite high for this company. Latest acquisition makes little sense and appears that they overpaid...for whatever it is that they actually acquired in the purchase.

    Company is not growing organically, only through acquisition, which they are funding by issuing debt. This is not a good model.

    Class action lawsuits are outstanding questioning compensation of CEO - which does raise the question of why the guy is getting paid so much, because it is surely not as a result of good company performance.

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2101963, ~/Articles/ArticleHandler.aspx, 10/20/2016 5:58:47 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,162.35 -40.27 -0.22%
S&P 500 2,141.34 -2.95 -0.14%
NASD 5,241.83 -4.58 -0.09%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/20/2016 4:00 PM
ANGO $17.31 Up +0.20 +1.17%
AngioDynamics CAPS Rating: ***
BCR $220.19 Down -0.02 -0.01%
C.R. Bard CAPS Rating: ****
BSX $23.01 Up +0.14 +0.61%
Boston Scientific CAPS Rating: ***